BRIEF-Galectin Therapeutics Q2 loss per share $0.20
August 09, 2016 at 08:15 AM EDT
* Galectin therapeutics reports second quarter 2016 financial results and provides business update
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.